Project Grant R21MH137546
Award Date
8/15/24
Completion Date
8/14/26
Dollars Obligated
$439K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Stony Brook, NY 11794, USA
Similar Awards
This Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support research to determine the physiological and behavioral role of ventral tegmental area (VTA) neurons that co-release the neurotransmitters GABA and glutamate in the amygdala. The $248,998 grant will fund experiments by the Principal Investigator, who is moving to a tenure-track position at Dartmouth College, to monitor the activity of...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $182,993 to support a research project titled "Thalamostriatal Regulation of Acetylcholine During Reversal Learning". The research aims to investigate the role of acetylcholine release in the dorsomedial striatum and its regulation by thalamostriatal projections during reversal learning, a form of cognitive flexibility impaired in...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $808,417 to Stony Brook University to conduct a mechanistic clinical trial evaluating the role of the metabotropic glutamate receptor subtype 5 (mGluR5) in the antidepressant mechanism of cognitive behavioral therapy for insomnia (CBT-I). The 5-year research project, starting on May 1, 2025, aims to determine if CBT-I can reduce mGluR5...
This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $460,855 to New York University School of Medicine to investigate the cellular and circuit mechanisms by which acetylcholine (ACh) promotes associative learning in the primary somatosensory cortex. The key objectives are to: 1) use fluorescent ACh sensors and chemogenetic techniques to study the magnitude and time course of ACh release during different phases of an...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242, Mental Health Research Grants, will support a 5-year, $775,706 study to investigate the neural mechanisms and functional impacts of reducing anticholinergic burden in mid- to late-life schizophrenia spectrum disorders (SSD). The study will enroll 80 SSD patients, ages 40-70, in a randomized controlled trial to assess the effects of anticholinergic medication reduction on cognition, quality of life,...
This federal Project Grant award of $606,029.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the neurocircuitry underlying motivated reward-seeking behavior in response to stress. The key goals of the research are to: 1) Determine if a subpopulation of GABAergic neurons in the medial habenulo-interpeduncular (MHB-IPN) axis...
This federal Project Grant award, valued at $2,187,775.00 and awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), aims to develop novel positive allosteric modulators (PAMs) of the high sensitivity α4β2 nicotinic acetylcholine receptor (nAChR) subtypes to better understand the role of this receptor in nicotine's behavioral effects. The project, funded under CFDA 93.279 - Drug Use and Addiction Research Programs, will synthesize and...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), seeks to advance the understanding of the etiology of major depression by integrating genetic, epidemiological, developmental, and molecular genetic data from national health registers in Denmark and Sweden. The $593,104 award to Virginia Commonwealth University will fund a 5-year research project to: 1) harmonize data on genetic and environmental risk...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to measure the interactions between striatal adenosine-dopamine receptors and their impacts on behaviors. The $404,440 grant, awarded on February 19, 2025, will support research conducted by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the role of adenosine 2A receptor (A2AR) and...
The National Institute of Mental Health (NIMH) awarded a $760,143 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Maryland, Baltimore to conduct research on the role of acetylcholine and cannabinoid signaling in working memory and motivation. The 5-year project, titled "Endocannabinoid Control of Cholinergic Transmission and the Pursuit of Reward," aims to investigate how the interaction between acetylcholine and cannabinoid type 1 receptors in the...